Lab Results Uncover Insights for Marketers
Read an interesting article by Jason Bhan, M.D., Chief Medical Officer of Prognos, here on on PM360.
What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General...
Available Omnichannel HCP Data Sources
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share...
Biomarker Testing in Non-Small Cell Lung Cancer
By Bill Bowman, Clinical Solutions Architect
Clinical Diagnostic Data for Omnichannel HCP Marketing
A 5 Part Series By Matt Apprendi, VP of Digital Products We’re excited to write about one of the...
HbA1c scores influence HCPs’ therapy choices
Diabetes is one of many conditions where lab testing plays a critical role.
Optimizing Oncology Sales and Marketing with Lab Data
Rather than prescribing every cancer patient the same treatment regimen, oncologists and other...
Diabetes and RA: Further Explanations for Comorbidity
Why, how, and what might be next? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener
Comorbidity Between Diabetes and RA
How is comorbidity affected by a double positive? By Jason Bhan, MD, Fernando Schwartz, PhD, and...